Back to Top Skip to main content

Sidebar Navigation

The How and Why of Deprescribing; Institute for Healthcare Improvement IHI

There’s much talk and publicity about weaning people off drugs, or what is referred to as “deprescribing,” a process that entails taking patients off some of their medications or tapering down the dosages. A growing number of healthcare organizations are working on how to safely implement deprescribing. At Ascension, one hospital is focusing on deprescribing (or, whenever possible, not introducing) opioids and sedatives among a targeted group of patients; three other hospitals are zeroed in on deprescribing proton pump inhibitors for gastrointestinal problems because of potential harm caused by long-term use. Listen in as the panelists share what they’ve learned about deprescribing initiatives.

Speakers:

  • Nicole Brandt, PharmD, MBA, BCGP, BCPP, FASCP, executive director, Peter Lamy Center on Drug Therapy and Aging; professor, University of Maryland School of Pharmacy
  • Florian Daragjati, PharmD, BCPS, director, Ascension Center of Excellence for Antimicrobial Stewardship and Infection Prevention
  • Lynn Deguzman, PharmD, BCGP, regional clinical operations manager, Kaiser Permanente Leslie J. Pelton, MPA, director, IHI Leanne Phillips, PharmD, BCPS, clinical pharmacy coordinator, St. Vincent’s East, Ascension
Learn More
  • Start Date: 9/13/2018, 2:00 PM
  • End Date: 9/13/2018, 3:00 PM

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.